Search
for
Sort by
Research 241–270 of 711
- Pharmacodynamic Evaluation: Endocrinology
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: Perspective for a biological origin of sexual dysfunction in PCOS
- On the effects of testosterone on brain behavioral functions
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Epigenetic regulation of 5α reductase-1 underlies adaptive plasticity of reproductive function and pubertal timing
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Retinoic-Acid-Related Orphan Receptor Alpha Is Involved in the Regulation of the Cytoskeleton of Hair Follicle Stem Cells
- Bicalutamide: A review
- Treatment options for polycystic ovary syndrome
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Redefining hormone resistance in prostate cancer
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- The investigation and management of hirsutism
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Framework guidelines for the process of caring for the health of adolescent transgender (T) and non-binary (NB) people experiencing gender dysphoria — the position statement of the expert panel
- Polycystic ovarian syndrome elevates the distress of sexual pain in Iranian women with infertility
- The association of medications and supplements with human male reproductive health: a systematic review
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals
- Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report